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Abstract
Background: Infections of the central nervous system (CNS) with herpes- or enterovirus can be self-limiting and
benign, but occasionally result in severe and fatal disease. The polymerase chain reaction (PCR) has revolutionized
the diagnostics of viral pathogens, and by multiple displacement amplification (MDA) prior to real-time PCR the
sensitivity might be further enhanced. The aim of this study was to investigate if herpes- or enterovirus can be
detected in cerebrospinal fluid (CSF) from patients without symptoms.
Methods: Cerebrospinal fluid (CSF) samples from 373 patients lacking typical symptoms of viral CNS infection were
analysed by real-time PCR targeting herpesviruses or enteroviruses with or without prior MDA.
Results: In total, virus was detected in 17 patients (4%). Epstein-Barr virus (EBV) was most commonly detected, in
general from patients with other conditions (e.g. infections, cerebral hemorrhage). MDA satisfactorily amplified viral
DNA in the absence of human nucleic acids, but showed poor amplification capacity for viral DNA in CSF samples,
and did not increase the sensitivity for herpes virus-detection with our methodology.
Conclusions: Viral pathogens are rarely detected in CSF from patients without signs of CNS infection, supporting
the view that real-time PCR is a highly specific method to detect symptomatic CNS-infection caused by these
viruses. However, EBV may be subclinically reactivated due to other pathological conditions in the CNS.
Background
Herpes viruses are neurotropic and may cause encephali-
tis, a serious condition with mortality rates around 10-20%
overall mortality and up to 20-30% for untreated Herpes
simplex-1 (HSV-1) encephalitis. Therefore the detection of
these viruses in patients with suspected viral infections of
the central nervous system (CNS) is well studied [1-7].
Due to their neurotropism, alpha-herpesviridae may reside
latently in neurons after the primary infection. Dormant
viruses may subsequently reactivate and cause symptoms
of meningoencephalitis. However, it is not known if viral
particles are shed into the cerebrospinal fluid (CSF) during
the latent phase, since few studies have investigated the
presence of herpes viruses in the CSF of patients lacking
symptoms of viral CNS infection [8,9]. In an earlier study,
Davies et al. showed that viral nucleic acid (NA) could be
detected by PCR in 5% of patients classified as having a
low probability of CNS infection [8].
Although PCR is a highly sensitive method for detec-
tion it may not always be sensitive enough for identifica-
tion of viral DNA in CSF, due to the fact that viral
shedding from latent infection may be very low. Multiple
displacement amplification (MDA), a whole genome
amplification (WGA) method for isothermal uniform
amplification of total DNA, might serve to increase the
sensitivity of the polymerase chain reaction (PCR)[10,11].
To our knowledge only a few studies have used MDA in
connection with viral detection [12-14].
The aims of this project were to investigate the possibi-
lity to detect viral nucleic acid in CSF from patients with-
out clinical symptoms or signs of viral infection and if
herpes- or enterovirus might cause symptoms mistaken
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increase the sensitivity by amplifying total DNA with
MDA prior to real-time PCR.
Methods
Patients
Samples of CSF from 373 patients from Östergötland
County were included in the study (Table 1). No viral
analysis had been performed on the majority of these
samples. Samples from two groups of patients were stu-
died. Patient group 1 included samples from 167 patients
that were sent to the clinical microbiological laboratory
at the Linköping University Hospital, for bacterial culture
because of a suspected bacterial infection in the CNS.
The patients in this group had symptoms ranging from
low-grade fever with or without increased white blood
cells (WBC) in blood or CSF, to acute onset of decreased
consciousness, confusion and sepsis. These samples were
collected consecutively between January and September
2008. Patient group 2 consisted of 206 patients, who’s
CSF, collected consecutively from January to March and
June to July 2007, had been previously analyzed serologi-
cally for neuroborreliosis. Many of these patients had dif-
fuse symptoms such as persistent or intermittent
headaches; others had a history or symptoms that can be
indicative of neuroborreliosis. Four patients out of the
206 (2%) in this group were diagnosed with neuroborre-
liosis using the IDEIA™ Lyme Neuroborreliosis EIA kit
(Oxoid Ltd, Ely UK).
Viral nucleic acid extraction
Total nucleic acid was extracted from 200 μlC S Fu s i n g
MagAttract Virus Mini M48 kit (Qiagen, Solna, Sweden)
according to manufacturer’si n s t r u c t i o n sa n de l u t e di n
75 μl. All samples were frozen after extraction and after
MDA-treatment, when performed.
MDA
GenomiPhi V2 DNA Amplification kit (GenomiPhi, GE
Healthcare, Stockholm, Sweden) was used according to
manufacturer’s instructions on 76 samples, with modifi-
cation for using 10 μl of DNA extract without sample
buffer to maximize initial DNA content. The amplifica-
tion capacity of MDA for each virus was evaluated by
mixing positive herpesvirus DNA controls (Vircell, Santa
Fé, Spain) in nuclease-free w a t e ro rC S Fa tv a r i o u sc o n -
centrations. Real-time PCR results were compared for
samples with and without MDA treatment. For this eva-
luation GenomiPhi was used with either 5 μlt e m p l a t e
mixed in 5 μl sample buffer, or with 10 μl template with-
out sample buffer. REPLI-g Mini kit (Qiagen) was also
used for this evaluation according to the manufacturers’
recommendations with 5 μl template.
Real-time PCR
Real-time PCR reactions were performed on Rotor-Gene
(Corbette Life Science, Sydney, Australia). Extracted sam-
ples with and without MDA treatment were thawed and
analyzed in parallel. HSV-1 and HSV-2 were analyzed
with 1X QuantiTect SYBR Green Master Mix (Qiagen),
5 μl template in a final volume of 25 μl. PCR for detection
of Varicella zoster virus (VZV) followed the same protocol
as HSV-1 and HSV-2, but using 1X QuantiFast Probe
Master Mix (Qiagen). Sample results were analyzed for
cycle threshold values and melting curve analysis for HSV-
1 and HSV-2. Commercial kits Artus EBV RG PCR kit V1
(Qiagen) and Artus CMV RG PCR kit V1 (Qiagen) were
used according to the manufacturer’s instructions. Entero-
virus was detected with RNA UltraSense™ One-Step
Quantitative RT-PCR System (Invitrogen, Paisly, United
Kingdom) according to manufacturer’s instructions, with
1X RNA UltraSense™ Reaction mix, 3 mM MgSO4,
1.25 μl UltraSense™Enzyme mix and 10 μlt e m p l a t et oa
final volume of 25 μl. Primers and probes for detection are
shown in Table 2. In Patient group 1, real-time PCR analy-
sis included 167 samples for Human herpes virus (HHV) 1
to 5 and samples from 93 patients for enterovirus. In
Patient group 2, corresponding PCR analysis included 206
samples for HHV 1 to 4, 171 samples for cytomegalovirus
(CMV) and samples from 110 patients for enterovirus.
Results
Real-time PCR
Out of totally 167 patients in Patient group 1, with sus-
pected bacterial CNS infection, viral NA was detected in
the CSF of 15 patients using real-time PCR (Table 3).
Epstin-Barr virus (EBV) was the most common viral DNA
detected (9 patients). As described in Table 4, CNS symp-
toms was due to non-infectious causes in several cases; sub-
arachnoid or cerebellar hemorrhage (n = 5), tumors (n = 3)
or was explained by bacterial infection (n = 4) or shunt dys-
function (n = 2). In two cases, EBV DNA was detected
together with HSV-1 or VZV DNA. Among the 206
patients with possible neuroborreliosis, (Patient group 2),
viral NA (EBV) was detected in two cases.
MDA
Five samples (one each of HSV-1, HSV-2 and CMV, and
two EBV) in which viral DNA was detected by PCR
Table 1 Sample population of patients
Age Gender distribution Total
Median Range Men (%) Women (%) Patients
Patient group 1 55 0-86 79 (47) 88 (53) 167
Patient group 2 49 3-84 92 (45) 114 (55) 206
Patient group 1 consisted of samples that were sent for bacterial culture
because of a suspected bacterial infection in the CNS. Patient group 2
consisted of samples that had been previously analyzed for neuroborreliosis.
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versely, one sample from Patient group 1 was positive for
HHV DNA only after MDA amplification. This sample
showed a very weakly positive signal after MDA treat-
ment, suggesting that the amount of viral NA was close
to the assay cut off. EBV was detected in two samples
both with and without MDA. These two EBV samples
displayed higher Ct values for MDA products, suggesting
that MDA did not increase the sensitivity for viral DNA.
Since MDA did not increase the sensitivity for detecting
HHV it was not performed on more than 76 samples.
A reason why MDA-treatment did not increase sensi-
tivity could be that viral DNA is scarce in CSF compared
to the amount of human genomic DNA. Therefore we
studied the amplification of viral DNA from infected cell
cultures. MDA-treated viral DNA diluted in CSF com-
pared to water showed a poorer amplification for viral
DNA, particularly at lower concentrations. These results
suggest that MDA negatively discriminates viral DNA in
presence of human nucleic acid.
Discussion
In this study we found no support for low-grade or
intermittent shedding of latent HHV DNA into the CSF
in patients without signs of viral CNS infection. The
identification of viral NA in samples sent for bacterial
culture is interesting and probably reflects that clinical
symptoms are not easily categorised as due to bacterial
or viral infection in the CNS. Probably, bacterial culture
is requested also in the absence of typical meningitis in
patients who are old, have a complex medical history or
are immunologically suppressed.
Viral NA was detected in 15 samples (8%) sent for bac-
terial culture on the suspicion of possible bacterial CNS
infection (Patient group 1). HSV-1, HSV-2 or VZV DNA
was detected in 6 of these cases. Five of these had a clini-
cal presentation compatible with viral meningitis or ence-
phalitis, while such symptoms were absent in one case
(Pat no 2). CMV was detected in one patient, but the
clinical picture did not support CMV-caused infection.
EBV DNA was detected in 9 patients in Group 1, but
o n l yf e wo ft h e mh a ds i g n so fC N Si n f e c t i o na n dn o n e
had symptoms typical for EBV infection (fever, mononu-
cleosis). It has been described that EBV can cause CNS
infections by itself, particularly in immunocompromised
patients [15-18] but EBV DNA has also been detected in
CSF and synnovial fluid from patients without likely
EBV-infection [8,9,19]. Our results support the latter, but
Table 2 Primers and probes for HSV-1, HSV-2, VZV and enterovirus
Virus Primer or probe Sequence (5’-3’) Primer/probe concentration
HSV-1
1 Forward CCATACCGACCACACCGACGA 400 nM
Reverse CATACCGGAACGCACCACAC 400 nM
HSV-2
1 Forward TCAGCCCATCCTCCTTCGGC 400 nM
Reverse GCGCGGTCCCAGATCGG 400 nM
VZV Forward TGCAGGGCATGGCTCAGT 400 nM
Reverse CCCAAGAACCACATGTCCAAC 400 nM
Probe TCCAGGGACTTGGGACC 200 nM
Enterovirus Forward CCTGAATGCGGCTAATCCYAAC
2 400 nM
Reverse CRATTGTCACCATAAGCAGCCA
3 900 nM
Probe CCCAAAGTAGTCGGTTCCGCCACAGA 150 nM
1 Primers for HSV-1 and modified primers for HSV-2 from Franzén-Röhl 2008
7.
2 Degenerate primer, Y = T or C.
3 Degenerate primer, R = G or A.
Table 3 Real-time PCR detected viral DNA in the two patient groups
Virus Patient group 1 (167 tot) Patient group 2 (206 tot)
Positive Percent Positive Percent
HSV-1 2 1% 0 0%
HSV-2 1 0.6% 0 0%
VZV 1 0.6% 0 0%
EBV 7 4% 2 1%
CMV 1 0.6% 0 0%
EV 1 0.6% 0 0%
HSV-2 + EBV 1 0.6% 0 0%
VZV + EBV 1 0.6% 0 0%
Total positive patients 15 9% 2 1%
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Page 3 of 6Table 4 Clinical and laboratory finding in patients positive for virus in CSF
Symptoms blood CSF
Pat Age Sex Results Admission cause Enceph Mening WBC CRP WBC Poly Mono Diagnosis AVT
1 77 M EBV acute onset, reduced conciousness No No 11 62 5 2 3 SAH, bacterial infection
2 64 F VZV EBV fever, decreased consciousness No No 9 45 427 170 257 Brain tumor
3 53 M HSV2 EBV fever, decreased consciousness No Yes 11 109 135 27 108 Brain hemorrhage, meningitis
4 53 M HSV1 headache, personality change Yes No 8 < 10 0.5 0.4 0.1 Hydrocephalus/encephalitis
5 82 M CMV fever, post op cerebi No No 17 63 21 5 16 Meningioma, infection
6 86 F EV fever, decreased consciousness Yes Yes 10 140 1.4 0 1.4 Herpes zoster, bacteremia yes
7 61 F EBV post op double vision, CSF leakage No No 10 < 10 1315 515 800 Meningioma, post-op meningitis
8 70 F HSV2 sudden headache No Yes 6 11 103 18.6 84 HSV2 meningitis
9 58 M HSV1 acute confusion, dysphasia Yes No 16 < 10 27 0.6 26 HSV1 encephalitis yes
10 52 F EBV dizziness, vomiting, headache No No 18 89 104 n.d n.d. SAH
11 56 M VZV Rash, decreased consciousness No Yes 6 111 26 0 26 varicella meningitis yes
12 65 M EBV Fever, post op cerebri No No 11 32 150 2 148 Spinal metastasis, S. aureus inf
13 65 M EBV ventricular shunt dysfunction No No 5.5 < 10 109 3 106 ventricular shunt dysfunction
14 63 M EBV fever post-op No No 9 < 10 1.7 0.1 1.6 SAH
15 54 F EBV acute headache No No 16 98 96 n.d. n.d SAH, pneumonia
16 60 F EBV dizziness, arm weakness No No 6 < 10 1 0.2 0.6 cerebrovascular disease
17 40 F EBV double vision, dysphasia, headache Yes No 14 < 10 514 10 504 Borrelia yes
SAH: subarachnoidal hemorrhage, Enceph: encephalitis, Mening: meningitis, WBC: white blood cells, CSF: cerebrospinal fluid, CRP: C-reactive protein, Poly: polymorphonuclear cells, Mono: mononuclear cells, AVT:
antiviral treatment, n.d.: not determined.
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6it is important to note that our material primarily is from
patients without suspected viral infection.
It is to our knowledge not yet known if EBV DNA
detected in the CSF origins from the CNS itself or from
infiltrative white blood cells due to inflammation. The
explanation that EBV is borne by WBCs may be favoured,
since we could only detect EBV in patients with other
traumatic and/or inflammatory processes in the CNS, see
Table 4.
Viral NA (EBV) was detected in only two of the samples
in Patient group 2 (0.5%). One patient had a clinical pre-
sentation characteristic for neuroborreliosis, and did not
have fever or other signs of EBV infection. The other
p a t i e n th a dn os i g n so fi n f e c t i o nb u ts u f f e r e df r o mc e r e -
brovascular disease. The more rare detection of viral NA
in Patient group 2 was not surprising because the majority
of these samples were collected from patients with diffuse
symptoms of long duration, drawn because the clinician
wanted to exclude the possibility of neuroborreliosis.
Enterovirus infections in the CNS are common and
may present as meningitis in a manner that may mimic
bacterial infection. Still, enterovirus RNA was detected in
only one positive sample in Patient group 1 and the sam-
ple was very weakly reactive. The patient did not have
typical symptoms for enterovirus infection, nor increased
white blood cells in the CSF.
The absence of detectable viral NA suggests that
viruses were not present in the CSF or that our methods
for detection are still not sensitive enough. Most real-
time PCR methods detect 1 to 10 viral particles/PCR
reaction, but the concentration of these viruses in CSF
during subclinical infection might be very low. A higher
sensitivity could probably be achieved by using larger
CSF extraction volumes (5-20 ml), but in general this is
not practically possible.
In our study, MDA amplified viral DNA satisfactorily
in the absence of other nucleic acids, but showed poor
amplification capacity for viral detection in CSF and did
not overall increase the sensitivity for HHV detection
with our methodology. A possible explanation why viral
DNA was not amplified could be the viruses’ shorter gen-
ome, the nature of viral DNA, or as reported in a study of
H. pylori DNA, impact from excess of human genomic
DNA [20]. The reportedly good performance of MDA
amplification for human papilloma virus (HPV) and
human immunodeficiency virus (HIV) may be explained
by the fact that in these cases, viral DNA can be inte-
grated into the human genome [13,21]. This suggests
that HHV DNA, which is not inserted into the human
genome, is discriminated by this method.
Conclusions
In summary, our results show that viral infection, in
particular HSV and VZV, should be suspected in
patients with putative bacterial CNS infection. Con-
versly, patients presenting clinical symptoms suggesting
HSV-1 encephalitis may have bacterial cause e.g. listerial
infections [22,23]. The findings also indicate that MDA
does not serve to enhance the performance of real-time
PCR, which alone is a both highly sensitive and specific
method for detecting viral CNS infections.
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